Literature DB >> 23304684

Validity of evaluation approaches for outbreak detection methods in syndromic surveillance systems.

M Karami1.   

Abstract

Entities:  

Year:  2012        PMID: 23304684      PMCID: PMC3521881     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor in Chief

Timely response to health events such as emerging diseases and outbreaks are a major public health priority. Outbreak detection methods and algorithms as the main tools for public health surveillance systems are under the umbrella of temporal and spatial methods (1). “There are three different approaches which might be used by syndromic surveillance systems to examine the performances of outbreak detection algorithms including real data testing, fully synthetic simulation and semi-synthetic simulation(2).” The first approach, i.e. real data testing, provide the highest degree of validity (3). Nevertheless, surveillance data for many of disease outbreaks or bioterrorist threats are not existent (4). Accordingly, there are few published studies in literature which evaluated the efficacy of the outbreak detection methods using real data testing approach (5–7). Consider to lack of surveillance data and need to know the performances of such outbreak detection algorithms under a wide range of outbreaks, semi-synthetic simulation approach were used by researchers (8–11). This evaluation approach allows the researcher to measure the performance of the algorithms at different circumstances at the expense of lower degree of validity in comparison to real data testing approach. During the past ten years both simulated datasets and simulation software have been developed to evaluate outbreak detection methods with their own limitations including the hypothetical basis (12–16). Watkins RE and his colleagues developed a simulation method that allows evaluator to consider the distribution, size and shape of the real outbreaks in order to achieving higher degree of validity (16). In the remainder of the letter, three strategies to improve the validity of the semi-synthetic simulation approach according to the author knowledge are explained. Considering the similarity of historical data on disease outbreaks in the literature and the size, shape and distribution of the injected spikes into non-outbreak baseline data can support the validity of your evaluation results as the first strategy. The similarity of the injected spikes and the previous outbreaks according to surveillance data, if the surveillance data on the interested disease or syndrome are available, should be considered as the second strategy. Considering the dynamic of disease’s transmission for different locations and circumstances through expert’s opinions is the last strategy to make a valid evaluation.
  13 in total

1.  Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales.

Authors:  Anna Goldenberg; Galit Shmueli; Richard A Caruana; Stephen E Fienberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Benchmark data and power calculations for evaluating disease outbreak detection methods.

Authors:  Martin Kulldorff; Z Zhang; J Hartman; R Heffernan; L Huang; F Mostashari
Journal:  MMWR Suppl       Date:  2004-09-24

3.  High-fidelity injection detectability experiments: a tool for evaluating syndromic surveillance systems.

Authors:  Garrick L Wallstrom; M Wagner; W Hogan
Journal:  MMWR Suppl       Date:  2005-08-26

4.  Real time detection of a measles outbreak using the exponentially weighted moving average: does it work?

Authors:  Manoochehr Karami; Hamid Soori; Yadollah Mehrabi; Ali Akbar Haghdoost; Mohammad Mehdi Gouya
Journal:  J Res Health Sci       Date:  2012

5.  Detection of pediatric respiratory and gastrointestinal outbreaks from free-text chief complaints.

Authors:  Oleg Ivanov; Per H Gesteland; William Hogan; Michael B Mundorff; Michael M Wagner
Journal:  AMIA Annu Symp Proc       Date:  2003

6.  Implementing syndromic surveillance: a practical guide informed by the early experience.

Authors:  Kenneth D Mandl; J Marc Overhage; Michael M Wagner; William B Lober; Paola Sebastiani; Farzad Mostashari; Julie A Pavlin; Per H Gesteland; Tracee Treadwell; Eileen Koski; Lori Hutwagner; David L Buckeridge; Raymond D Aller; Shaun Grannis
Journal:  J Am Med Inform Assoc       Date:  2003-11-21       Impact factor: 4.497

7.  Detection of pediatric respiratory and diarrheal outbreaks from sales of over-the-counter electrolyte products.

Authors:  William R Hogan; Fu-Chiang Tsui; Oleg Ivanov; Per H Gesteland; Shaun Grannis; J Marc Overhage; J Michael Robinson; Michael M Wagner
Journal:  J Am Med Inform Assoc       Date:  2003-08-04       Impact factor: 4.497

8.  A software tool for creating simulated outbreaks to benchmark surveillance systems.

Authors:  Christopher A Cassa; Karin Iancu; Karen L Olson; Kenneth D Mandl
Journal:  BMC Med Inform Decis Mak       Date:  2005-07-14       Impact factor: 2.796

9.  A simulation study comparing aberration detection algorithms for syndromic surveillance.

Authors:  Michael L Jackson; Atar Baer; Ian Painter; Jeff Duchin
Journal:  BMC Med Inform Decis Mak       Date:  2007-03-01       Impact factor: 2.796

10.  Time series modeling for syndromic surveillance.

Authors:  Ben Y Reis; Kenneth D Mandl
Journal:  BMC Med Inform Decis Mak       Date:  2003-01-23       Impact factor: 2.796

View more
  2 in total

1.  Seasonal Activity of Influenza in Iran: Application of Influenza-like Illness Data from Sentinel Sites of Healthcare Centers during 2010 to 2015.

Authors:  Seyedhadi Hosseini; Manoochehr Karami; Maryam Farhadian; Younes Mohammadi
Journal:  J Epidemiol Glob Health       Date:  2018-12

2.  Forecasting the monthly incidence rate of brucellosis in west of Iran using time series and data mining from 2010 to 2019.

Authors:  Hadi Bagheri; Leili Tapak; Manoochehr Karami; Zahra Hosseinkhani; Hamidreza Najari; Safdar Karimi; Zahra Cheraghi
Journal:  PLoS One       Date:  2020-05-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.